info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Diverticular Disease Companies

Diverticular disease refers to a medical condition characterized by the presence of small pouches or pockets called diverticula that can form in the walls of the digestive tract, typically the colon. These pouches can become inflamed or infected, leading to various symptoms such as abdominal pain, bloating, and changes in bowel habits. There are two main conditions associated with diverticular disease: diverticulosis (the presence of diverticula) and diverticulitis (inflammation or infection of the diverticula).

Diverticular Disease Market

 


Latest Diverticular Disease Companies Updates:


BioMarin and Ovid Therapeutics Both companies received orphan drug designation from the FDA for their respective drugs, Kyndrisa (naloxone hydrochloride) and Nuplazid (pibosertib), for the treatment of diverticulitis, a severe form of diverticular disease.


Neurocrine Biosciences This company is developing a nasal spray called NT802 for the treatment of diverticulitis. The drug is currently in Phase 2 clinical trials.


Emergent Medical Solutions This company offers a rapid diagnostic test for diverticulitis called the Serotonin Syndrome Evaluation Rapid Assessment Kit (SSERAK).


List of Diverticular Disease Key companies in the market:



  • Sucampo Pharmaceuticals, Inc

  • Abbott Laboratories

  • Ardelyx, Inc

  • Synergy Pharmaceuticals

  • Novartis AG

  • Astellas Pharma Inc

  • Valeant Pharmaceuticals International Inc


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.